SCHEMBL26548178

SCHEMBL26548178

C[Si](C)(C)c1ccc(-c2ccc3cc(-c4ccc(-c5ccc6ccccc6c5)nc4)ccc3c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 4/20 0.45
CYP11B2 P19099 4/20 0.45
CYP17A1 P05093 1/20 0.45
CYP19A1 P11511 1/20 0.45
HSD17B1 P14061 1/20 0.44
HSD17B2 P37059 1/20 0.44
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
CYP1A2 P05177 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
LPL P06858 1/20 0.40
LIPG Q9Y5X9 1/20 0.40
ALDH1A1 P00352 4/20 0.40
AR P10275 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
CYP2C9 P11712 2/20 0.40
HPGD P15428 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
KDM4E B2RXH2 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548691 0.98 CYP11B2 (0.44) CYP11B1CYP11B2CYP17A1CYP19A1HSD17B1
SCHEMBL26549193 0.92 PDGFRB (0.41) CYP11B1CYP11B2CYP17A1CYP19A1HSD17B1
SCHEMBL26548367 0.91 HSD17B1 (0.41) CYP11B1CYP11B2CYP17A1CYP19A1HSD17B1
SCHEMBL26548853 0.89 HSD17B1 (0.40) CYP11B1CYP11B2CYP17A1CYP19A1HSD17B1
SCHEMBL26548214 0.89 PDGFRB (0.47) CYP11B1CYP11B2CYP17A1CYP19A1HSD17B1
SCHEMBL26548725 0.88 PDGFRB (0.46) CYP11B1CYP11B2CYP17A1CYP19A1HSD17B1
SCHEMBL26564732 0.85 CYP11B1 (0.56) CYP11B1CYP11B2CYP17A1CYP19A1HSD17B1
SCHEMBL13063101 0.85 ESR1 (0.55) CYP11B1CYP11B2CYP17A1CYP19A1HSD17B1
SCHEMBL26820142 0.85 ESR1 (0.55) CYP11B1CYP11B2CYP17A1CYP19A1HSD17B1
SCHEMBL26820135 0.85 ESR1 (0.55) CYP11B1CYP11B2CYP17A1CYP19A1HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 CYP11B1 1676/4885CYP11B2 1913/4885CYP17A1 1147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.